Bacteria caused by multi-resistant gram-positive microorganisms

Clinical Microbiology and Infection

Volumn 5, Issue SUPPL. 2, 1999, Pages

  Spencer, Robert C ^a  

^a BRISTOL ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; DALFOPRISTIN PLUS QUINUPRISTIN; EVERNINOMICIN; GLYCYLCYCLINE DERIVATIVE; OXAZOLIDINONE DERIVATIVE; QUINOLONE; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; BACTEREMIA; CATHETER INFECTION; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONFERENCE PAPER; GRAM POSITIVE BACTERIUM; HOSPITAL INFECTION; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; SEPSIS; UNITED KINGDOM;

BACTERIA (MICROORGANISMS); POSIBACTERIA; STAPHYLOCOCCUS;

EID: 13044274948     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (122)

1. Emori TG, Gaynes RP. An overview of nosocomial infections, including the role of the microbiology laboratory Clin Microbiol Rev 1993; 6: 428-42.
2. Howe RA, Brown NM, Spencer RC. The new threats of Gram-positive pathogens, re-emergence of things past. J Clin Pathol 1996, 49: 444-9.
3. Pitter D, Wenzel RP. Nosocomial bloodstream infections. Secular levels in rates, mortality and contribution to total hospital deaths. Arch Int Med 1995; 155 1177-84
4. Linden PK. Clinical implications of nosocomial Gram-positive bacteremia Am J Med 1998; 104: 245-335.
5. Banerjee SN, Emori TG, Culver DH, et al. Trends in nosocomial bloodstream infections in the United States, 1986-1990. Am J Med, 91: 865-95.
6. Weinstein MP, Towns ML, Quartey SM, et al. The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology and outcome of bacteremia and fungemia in adults. Clin Infect Dis 1997; 24: 584-602.
7. Jarvis WR, Martone WJ: Predominant pathogens in hospital infections. J Antimicrob Chemother 1992; 29(Suppl A): 19-24.
8. National Nosocomial Infection Surveillance (NNIS) Report, Data Summary for October 1986 to April 1996. Am J Infect Control 1996; 24: 380-8.
9. Pfaller MA, Jones RN, Doern GV, et al. Bacterial pathogens isolated from patients with bloodstream infection: frequences of occurrence and antimicrobial susceptibility pattern from the SENTRY antimicrobial surveillance program (United States and Canada, 1997). Antimicrob Agents Chemother 1998; 42: 1762-70.
10. Pfaller MA, Jones RN, Marshall SA, et al. Nosocomial streptococcal blood stream infections in the SCOPE Program: species occurrence and antimicrobial resistance. Diagn Microbiol Infect Dis 1997; 29: 259-63.
11. Jones RN. Impact of changing pathogens and antimicrobial susceptibility patterns in the treatment of serious infections in hospitalised patients. Am J Med 1996; 100: 35-125.
12. Spencer RC, Wheat PF, Magee JT, et al. A three year survey of clinical isolates in the United Kingdom and their antimicrobial susceptibility. J Antimicrob Chemother 1990; 26: 435-46.
13. Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients. J Am Med Assoc 1994; 271: 1598-601.
14. US Congress, Office of Technology Assessment, Impacts of Antibiotic-Resistant Bacteria, OTA-H-629. Washington DC. US Government Printing Office, September 1995.
15. Oppenheim BA. The changing pattern of infection in neutropenic patients. J Antimicrob Chemother 1998; 41(Suppl D): 7-11.
16. Schaberg DR, Culver DH, Gaynes RP. Major trends in the microbiol etiology of nosocomial infection. Am J Med 1991; 91 (Suppl B): 725-55
17. Jones RN, Marshall SA, Pfaller MA, et al. Nosocomial enterococcal blood stream infections in the SCOPE program. Diagn Microbiol Infect Dis 1997; 29: 95-102.
18. Arthur M, Courvalin P. Genetics and mechanisms of glycopeptide resistance in enterococci. Antimicrob Agents Chemother 1993; 37: 1563-71.
19. Vincent J-L, Bihari DJ, Suter PM, et al. The prevalence of nosocomial infections in intensive care units in Europe. J Am Med Ass 1995; 274: 639-44.
20. Spencer RC. Predominant pathogens found in the European Prevalence of Infection in Intensive Care Study. Eur J Clin Microbiol Infect Dis 1996; 15: 281-5.
21. Moellering RC. Problems with antimicrobial resistance in Gram-positive cocci. Clin Infec Dis 1998; 26: 1177-8.
22. Hiramatsu K, Aritaka N, Hamaki H et al. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 1997; 350: 1670-3.
23. Howe RA, Bowker KE, Walsh TR, et al. Vancomycin-resistant Staphylococcus aureus. Lancet 1998; 351: 602.
24. Doern GV, Ferraro MJ, Brueggermann AB, et al. Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States. Antimicrob Agents Chemother 1996; 40: 891-4.
25. Schwalbe RS, Stapleton JT, Gilligan PH. Emergence of vancomycin resistant coagulase-negative staphylococci. N Engl J Med 1987; 316: 927-31.
26. Uttley AH, George RC, Naidoo J, et al. High level vancomycin-resistant enterococci causing hospital infections. Epidemiol Infect 1989; 103: 173-81.
27. Seppala H, Nissinen A, Jarvinen H, et al. Resistance to erythromycin in Group A streptococci. N Engl J Med 1992; 326: 292-7.
28. Seppala H, Klankka T, Vuopio-Varkila J, et al. The effects of change in the consumption of macroslide antibiotics on erythromycin resistance in Group A streptococci in Finland. New Engl J Med 1997; 337: 447-56.
29. Felmingharn D, Gruneberg RN, The Alexander Project Group. A multicentre collaborative study of the antimicrobial sensitivity of community acquired lower respiratory tract pathogens 1992-1993: The Alexander Project. J Antimicrob Chemother 1996; 38 (Suppl A): 1-57.
30. Rupp ME, Archer GL. Coagulase-negative staphylococci: pathogens associated with medical programs Clin Infect Dis 1994; 19: 231-45.
31. Geerdes HF, Ziegler D, Lode H, et al. Septicemia in 980 patients at a University hospital in Berlin: prospective studies during 4 selected years between 1979 and 1989. Clin Infec Dis 1992; 15: 991-1002.
32. Arpi M, Renneberg J, Andersen HK, et al. Bacteremia at a Danish University hospital during a twenty-five year period (1968-1992). Scand J Infect Dis 1995; 27: 245-51.
33. Haug JB, Harthug S, Kalager T, et al. Bloodstream infections at a Norwegian University hospital, 1974-1979 and 1988-1989: changing etiology, clinical features and outcome. Clin Infect Dis 1994; 19: 246-56.
34. Raad I, Altrahwan A, Rolston K. Staphylococcus epidermidis: emerging resistance and need for alternative agents. Clin Infect Dis 1998; 26: 1182-7.
35. Anday EK, Talbot GH. Coagulase negative staphylococcus bacteremia - a rising threat in the newborn infant. Ann Clin Lab Sci 1985; 15: 246-51.
36. Fidalga S, Vanquez F, Mendoza MC, et al. Bacteremia due to Staphylococcus epidermidis, microbiologic, epidemiologic, clinical and prognostic features Rev Infect Dis 1990; 12: 520-8.
37. Kloos AWE, Bannerman TL. Update on clinical significance of coagulase-negative staphylococci. Clin Microbiol Rev 1994; 7: 117-40.
38. Ivert TSA, Dismukes WE, Cobbs CG et al. Prosthetic valve endocarditis. Circulation 1984; 69: 223-31.
39. Raad I. Intravascular-catheter-related infections. Lancet 1998; 351: 893-8.
40. Harbarth S, Rutschmann O, Sudre P, et al. Impact of methicillin-resistance on the outcome of patients with bacteremia caused by Staphylococcus aureus. Arch Intern Med 1998; 158: 182-9.
41. Pittet D. Nosocomial bloodstream infections. In: Wenzel RP ed., Prevention and Control of Nosocomial Infections, 3rd ed. Baltimore: Williams and Wilkins, 1997; 711-69.
42. Spencer RC. Indwelling devices and 40 prostheses: novel methods for the prevention of infection. J Hosp Infect 1999; in press.
43. Thylefors JD, Harbarta S, Pittet D. Increasing bacteremia due to coagulase-negative staphylococci: fiction or reality? Infect Control Hosp Epidemiol 1998; 19: 581-9.
44. Archer GL. Molecular epidemiology of multi-resistant Staphylococcus epidermidis. J Antimicrob Chemother 1988; 21 (Suppl): 133-8.
45. Froggart JW, Johnston JL, Galetto DW et al. Antimicrobial resistance in nosocomial isolates of Staphylococcus haemolyticus. Antimicrob Agents Chemother 1989; 33: 460-6.
46. Kotilainen P, Nikoskelainen J, Huovinen P. Emergence of ciprofloxacin resistant coagulase-negative staphylococcal skin flora in immunocompromised patients receiving ciprofloxacin. J Infect Dis 1990; 161: 41-4.
47. Musher DM, McKenzie SO. Infections due to Staphylococcus aureus. Medicine 1977; 56: 383-402.
48. Pujol M, Peva C, Pallares R, et al. Risk factors for nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis 1994; 13: 96-102.
49. Garabaldi RA. Catheter associated urinary tract infection. Curr Opin Infect Dis 1992; 5: 517-23.
50. Kaufhold A, Behrendt W, Kraus T, et al Selective decontamination of the digestive tract and methicillin-resistant Staphylococcus aureus. Lancet 1992, 339: 1141-412.
51. Cafferky MT, Hone R, Keane CT. Sources and outcome for methicillin-resistant Staphylococcus aureus bacteraemia. J Hosp Infect 1988; 11: 136-43.
52. Catchpole C, Wise R, Fraise A. MRSA bacteraemia. J Hosp Infect 1997; 35: 159-61.
53. Speller DCE, Johnson AP, James D, et al. Resistance to methicillin and other antibiotics in Staphylococcus aureus from blood and cerebrospinal fluid, England and Wales, 1989-95 Lancet 1997, 350: 323-5.
54. Johnson AP, James D. Continuing increase in invasive methicillin-resistant Staphylococcus aureus infections. Lancet 1997; 350: 1710.
55. Conterno LO, Wey SB, Castelo A. Rick factors for mortality in Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol 1998, 19: 32-7.
56. Frimoedt-Møller N, Esperson F, Skinhoj P, et al. Epidemiology of Staphylococcus aureus bacteremia in Denmark from 1957 to 1990. Clin Microbiol Infect 1997; 3: 297-305.
57. Romero-Vivas J, Rubio M, Fernandez C, et al. Mortality associated with nosocomial bacteraemia due to methicillin-resistant Staphylococcus aureus. Clin Infect Dis 1995; 21: 1417-23.
58. French GL, Cheng AFB, Ling JML, et al. Hong Kong strain of methicillin-resistant and methicillin-sensitive Staphylococcus aureus have similar virulence J Hosp Infect 1990; 15: 117-25.
59. Calain D, Krause KH, Vaudaux P, et al. Early termination of a prospective randomised trial comparing teicoplanin and flucloxacillin for treating severe staphylococcal infections. J Infect Dis 1987; 155: 187-91.
60. Rello J, Torres A, Ricart M, et al. Ventilator-associated pneumonia by Staphylococcus aureus: comparison of methicillin-resistant and methicillin-resistant and methicillin-sensitive episodes. Am J Respir Crit Care Med 1994; 150: 1545-911.
61. Hunt JL, Purdue GL, Tuggle DW Morbidity and mortality of an endemic pathogen: methicillin-resistant Staphylococcus aureus. Am J Surg 1988; 156: 524-7.
62. O'Kane GM, Gottlieb T, Bradbury R. Staphylococcal bacteremia: the hospital or the home? Aust NZ J Med 1998; 28: 23-7.
63. Husni R, Raad I Treatment and prevention of vancomycin-resistant enterococcus. Curr Opin Infect Dis 1997; 10: 431-4.
64. Hawley HB, Elder BL. Multiple-drug resistant enterococci: Laboratory identification, prevention and treatment. Antimicrob Infect Dis Newsletter 1997; 16: 65-8.
65. Noskin GA, Peterson LR, Warren JR. Enterococcus faecium and Enterococcus faecalis bacteremia: acquisition and outcome. Clin Infect Dis 1995; 20: 296-301.
66. Hoge CW, Adams J, Buchanan B, et al. Enterococcal bacteremia: to treat or not to treat, a reappraisal. Rev Infect Dis 1991; 13: 600-5
67. Landry SL, Kaiser DL, Wenzel RP. Hospital stay and mortality attributed to nosocomial enterococcal bacteremia: a controlled study. Am J Infect Control 1989; 17: 323-9.
68. Noskin GA, Till M, Patterson BK, et al. High-level gentamicin-resistance in Enterococcus faecalis bacteremia. J Infect Dis 1991; 164: 1212-15.
69. Watanakunakorn C, Patel R. Comparison of patients with enterococcal bacteremia due to strains with and without high-level resistance to gentamicm. Clin Infect Dis 1993; 17: 74-8.
70. Shay DK, Maloney SA, Montecalvo M, et al. Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections. J Infect Dis 1995; 172: 993-1000.
71. Tornieporth NG, Roberts RB, John J, et al. Risk factors associated with vancomycin-resistant Enterococcus faecium infection or colonisation in 145 matched case patients and control patients. Clin Infect Dis 1996; 23: 767-72.
72. Linden PK, Pasculle AW, Manez R, et al. Differences in outcome for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E. faecium Clin Infect Dis 1996; 22: 663-70.
73. Stroud L, Edwards J, Danzig L, et al. Risk factors for mortality associated with enterococcal bloodstream infections. Control Hosp Epidemiol 1996, 17: 576-80.
74. Mainous MR, Lipsett PA, O'Brien M and the Johns Hopkins SICU Study Group. Enterococcal bacteremia in the surgical intensive care unit: does vancomycin resistance affect mortality? Arch Surg 1997; 132: 76-81.
75. CDC. Nosocomial enterococci resistant to vancomycin-United States 1989-1992. MMWR 1993; 42: 597-9.
76. Wells CL, Juni BA, Camerson SB, et al. Stool carriage, clinical isolation and mortality during an outbreak of vancomycin-resistant enterococci in hospitalised medical and/or surgical patients. Clin Infect Dis 1995; 21: 45-50.
77. Centers for Disease Control and Prevention Recommendation for preventing the spread of vancomycin resistance: Recommendation of HICPAC. Infect Control Hosp Epidemiol 1995; 16: 105-13.
78. Edmond MB, Ober JF, Weinbaum DL et al. Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. Clin Infect Dis 1990; 20: 1126-33.
79. Weinstein JW, Roe M, Towns M, et al. Resistant enterococci: a prospective study of prevalence, incidence and factors associated with colonisation in a university hospital. Infect Control Hosp Epidemiol 1996; 17: 36-41.
80. Caron F, Leweland J-F, Humbert G et al. Triple combination penicillin-vancomycin-gentamicin for experimental endocarditis caused by a highly penicillin and glycopeptide-resistant isolate of Enterococcus faecium. J Infect Dis 1993; 168: 681-6.
81. Hayden MK, Trenholme GM, Schultz JE et al. In-vivo development of teicoplanin resistance in a Van B Enterococcus faecium isolate. J Infect Dis 1993; 167: 1224-7.
82. Howe RA, Robson R, Oakhill A, et al. Successful use of tetracycline as therapy of an immunocompromised patient with septicaemia caused by a vancomycin-resistant enterococcus. J Antimicrob Chemother 1997; 40: 144-5.
83. Goossens H. Spread of vancomycin-resistant enterococci: differences between the United States and Europe. Infect Control Hosp Epidemiol 1998; 19: 546-51.
84. Campbell GD, Silberman R. Drug-resistant Streptococcus pneumomae. Clin Infect Dis 1998; 26: 1188-95.
85. Kuikka A, Syrjanen J, Renkonen OV, et al. Pneumococcal bacteremia during a recent decade. J Infect 1992; 24: 157-68.
86. Klugman KP, Koornhof HJ. Bacteremic pneumonia caused by penicillin-resistant pneumococcci. N Engl J Med 1988; 318: 123-7.
87. Bouza E. Infeccion Neumococica: Patrones de susceptibilidad en España. Enfermedades Infecciosas y Microbiologia Clinica 1993; 11 (Suppl 1): 15-22.
88. Pallares R, Gudiol F, Linares J, et al. Risk factors and response to antibiotic therapy in adults with bacteremic pneumonia caused by penicillin-resistant pneumococcal. New Engl J Med 1987; 317: 18-22.
89. Martinez LM, Lopez-Hernandez I, Pascual A, et al. Resistance of Streptococcus pneumoniae to penicillin, erythromycin and third-generation cephalosporins in Seville, Southern Spain. Clin Microbiol Infect 1997; 3: 382-5.
90. Burman LA, Norrby R, Trollfors B. Invasive pneumococcal infections: incidence, predisposing factors, and prognosis. Rev Infect Dis 1995; 7: 133-42.
91. Gomez J, Bauos V, Ruiz-Gomez J, et al. Clinical significance of pneumococcal bacteraemias in a general hospital. a prospective study 1989-1993. J Antimicrob Chemother 1995; 36: 1021-30.
92. Gransden WR, Eykyn SJ, Phillips I. Pneumococcal bacteraemia: 325 episodes diagnosed at St Thomas's Hospital. B Med J 1985; 290: 505-8.
93. Marrie TJ. Bacteremic pneumococcal pneumonia a continuing evolution. J Infect 1992; 24: 247-55.
94. Pradier C, Dunais B, Carseuli-Elesse H, et al. Pneumococcal resistance patterns in Europe. Eur J Clin Microbiol Infect Dis 1997; 16: 644-7.
95. Johnson AP, Speller DCE, George RC et al. Prevalence of antibiotic resistance and serotypes in pneumococci in England and Wales: results of observational survey in 1990 and 1995. Bru Med J 1996; 312: 1454-6.
96. Friedland IR, McCraken GH. Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. N Engl J Med 1994; 331: 377-82.
97. Fine MJ, Smith MA, Carson CA et al. Efficacy of pneumococcal vaccination in adults: a meta-analysis of randomised controlled trials. Arch Intern Med 1994; 154: 2666-77.
98. Kaye D, McCormick RC, Hook EW. Bacterial endocarditis: The changing pattern since the introduction of penicillin therapy. Antimicrob Agents Chemother 1962; 1: 37-16.
99. Lerner PI, Weinstein L. Infective endocarditis in the antibiotic era. N Engl J Med 1966; 274: 323-31.
100. Bochud PY, Conietta A, Francioli P. Virulent infections caused by alpha-haemolytic streptococci in cancer patients and their management. Curr Opin Infect Dis 1997; 10: 422-30.
101. Elting LS, Bodey GP, Keefe BH: Septicemia and shock syndrome due to viridans streptococci: a case-control study of predisposing factors. Clin Infec Dis 1992; 14: 1201-7.
102. Cohen J, Worsely AM, Goldman JM et al. Septicaemia caused by viridans streptococci in neutropenic patients with leukaemia. Lancet 1983; 2: 1452-4.
103. Henslee J, Bostrom B, Weisdorf D et al. Streptococcal sepsis in bone marrow transplant patients Lancet 1984; 1: 393.
104. Braunstein H. Characteristics of group A streptococcal bacteremia in patients at the San Bernardino County Medical Center. Rev Infect Dis 1991; 13: 8-11.
105. Lentnek AL, Giger O, O'Rouke E. Group A beta-haemolytic streptococcal bacteremia and intravenous substance abuse. A growing clinical problem? Arch Intern Med 1990; 150: 89-93.
106. Schwartz B, Ussery XT. Group A streptococcal outbreaks in nursing homes. Infect Control Hosp Epidemiol 1992; 13: 742-7.
107. Harkness GA, Bentley DW, Mottley M et al. Streptococcus pyogenes outbreak in a long term care facility. Am J Infect Control 1992; 20: 142-8.
108. Dan M, Maximova S, Siegman-Igra Y, et al. Varied presentations of sporadic group A streptococcal bacteremia: Clinical experience and attempt at classification. Rev Infect Dis 1990; 12: 537-42.
109. Ispahani P, Donald FE, Aveline AJ. Streptococcus pyogenes bacteremia: An old enemy subdued but not defeated. J Infect 1988; 16: 37-46
110. Horn DL, Zabriskie JB. Why have Group A streptococci remained susceptible to penicillin? Report on a symposium. Clin Infect Dis 1998, 26: 1341-5.
111. Maruyama SH, Yoshioka H, Fujuta K, et al. Sensitivity of Group A streptococci to antibiotics: prevention of resistance to erythromycin in Japan. Am J Dis Child 1979; 133: 1143-5.
112. Cornaglia G, Ligozzi M, Mazzariol A, et al. Resistance of Streptococci pyogenes to erythromycin and related antibiotics in Italv. Clin Infect Dis 1998; 27 (Suppl 1): 587-92.
113. Jackman PJH, Pitcher DG, et al. Classification of corynebacteria associated with endocarditis (Group JK) as Corynebacterium jeikeium sp. Syst Appl Microbiol 1987; 9: 83-90.
114. Coyle MB, Lipsky BA. Coryneform bacteria in infectious diseases clinical and laboratory aspects. Clin Microbiol Rev 1990; 3: 227-46.
115. Petit PLC, Bok JW, et al. Native-valve endocarditis due to CDC coryneform Group ANF-3. report of a case and review of corynebacterial endocarditis. Clin Infect Dis 1994, 19: 897-901
116. Soniano F, Zapardiel J, Nieto E. Antimicrobial susceptibilities of Corynebacterium species and other non-spore-forming grampositive bacilli to 18 antimicrobial agents. Antimicrob Agents Chemother 1995; 39: 208-14.
117. Cornican MG, Jones RN. Emerging resistance to antimicrobial agents in Gram-positive bacteria Drugs 1996; 51 (Suppl 2): 6-12.
118. Maki DG. Infections associated with intravascular lines. In: Remington JS, Swartz MN eds, Current Clinical Topics in Infectious Diseases, Vol 3, 1982: 309-63.
119. Janssen B. Current approaches to the prevention of catheter-related infections. In: Seifert H, Janssen B, Farr BM eds, Catheter-related Infections, New York: Marcel Dekker, 1997: 411-46.
120. Pearson ML, The Hospital Infection Control Practices Advisory Committee: Guidelines for Prevention of Intravascular device-related infections. Infect Control Hosp Epidemiol 1995; 17: 438-73.
121. Spencer RC, Bauerfeind A, Garcia-Rodringuez J, et al. Surveillance of the current resistance of nosocomial pathogens to antibacterials. Clin Microbiol Infect 1997; 3(Suppl 1): S1-15.
122. Johnson AP Resistance in Gram-positive bacteria. J Hosp Infect 1998; 40: 17-26.